Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥178 | ¥169 | ¥165 | ¥180 |
| - Cash | ¥36 | ¥29 | ¥25 | ¥19 |
| + Debt | ¥1 | ¥1 | ¥1 | ¥1 |
| Enterprise Value | ¥143 | ¥141 | ¥141 | ¥163 |
| Revenue | ¥24 | ¥22 | ¥23 | ¥23 |
| % Growth | 6.5% | -2.1% | -2.3% | – |
| Gross Profit | ¥12 | ¥11 | ¥11 | ¥12 |
| % Margin | 49.1% | 49.9% | 48.3% | 50.5% |
| EBITDA | ¥5 | ¥3 | ¥5 | ¥6 |
| % Margin | 20.5% | 14.7% | 23% | 24.1% |
| Net Income | ¥3 | ¥5 | ¥3 | ¥4 |
| % Margin | 13.8% | 20.4% | 13.8% | 15.5% |
| EPS Diluted | 78.76 | 107.87 | 72.91 | 82.99 |
| % Growth | -27% | 47.9% | -12.1% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |